Privia Health Group, Inc. 8-K Filing
Ticker: PRVA · Form: 8-K · Filed: Dec 8, 2025 · CIK: 1759655
| Field | Detail |
|---|---|
| Company | Privia Health Group, Inc. (PRVA) |
| Form Type | 8-K |
| Filed Date | Dec 8, 2025 |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Privia Health Group, Inc. (ticker: PRVA) to the SEC on Dec 8, 2025.
What are the key financial figures in this filing?
Key dollar amounts include: $0.01 (ange on which registered Common Stock, $0.01 par value per share PRVA The Nasdaq Glo).
How long is this filing?
Privia Health Group, Inc.'s 8-K filing is 1 pages with approximately 409 words. Estimated reading time is 2 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 409 words · 2 min read · ~1 pages · Grade level 10.5 · Accepted 2025-12-08 08:01:00
Key Financial Figures
- $0.01 — ange on which registered Common Stock, $0.01 par value per share PRVA The Nasdaq Glo
Filing Documents
- prva-20251205.htm (8-K) — 22KB
- 0001759655-25-000113.txt ( ) — 139KB
- prva-20251205.xsd (EX-101.SCH) — 2KB
- prva-20251205_lab.xml (EX-101.LAB) — 23KB
- prva-20251205_pre.xml (EX-101.PRE) — 13KB
- prva-20251205_htm.xml (XML) — 3KB
01. Other Events
Item 8.01. Other Events. Previously, on September 23, 2025, Privia Health Group, Inc. (the "Company") announced the entry into a definitive agreement to acquire an Accountable Care Organization business from Evolent Health, Inc. The transaction closed on December 5, 2025.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PRIVIA HEALTH GROUP, INC. Date: December 8, 2025 By: /s/ David Mountcastle Name: David Mountcastle Title: Executive Vice President, Chief Financial Officer and Authorized Officer